Gladstone in the News
December 1, 2022
San Francisco Chronicle—In an update to a previous article, Senior Investigator Warner Greene now expects both COVID and flu to spread during the holidays and encourages people in high-risk groups to take extra precautions to avoid infection.
Gladstone Experts
COVID-19
Center for HIV Cure Research
Greene Lab
Gladstone in the News
November 17, 2022
San Francisco Chronicle—Senior Investigator Warner Greene, MD, PhD, shares his views on the likelihood of a new COVID surge this winter.
Gladstone Experts
COVID-19
Virology
Greene Lab
Gladstone in the News
November 15, 2022
Invisishield Technologies—Gladstone Senior Investigator Warner Greene has been appointed President and Chief Scientific Officer of Invisihield Technologies. Invisishield is focused on developing intranasal preventatives for respiratory viruses, including SARS-CoV-2.
Gladstone Experts
COVID-19
Virology
Greene Lab
Gladstone in the News
October 20, 2022
ABC7 News—Senior Investigator Nadia Roan, PhD, says that a winter surge of infections from the highly transmissible new variants of SARS-CoV-2 currently emerging in the US is likely, but it remains unclear how bad it will be.
Gladstone Experts
COVID-19
Virology
Roan Lab
Gladstone in the News
October 17, 2022
National Academy of Medicine—Katie Pollard, PhD, senior investigator and director of the Gladstone Institute of Data Science and Biotechnology, has been elected to the National Academy of Medicine, in recognition of her discovery of fast-evolving regions in the human genome associated with psychiatric diseases, and of her open-source software used worldwide by genome scientists.
Gladstone Experts
Data Science and Biotechnology
Pollard Lab
Big Data
Genomics
Human Genetics
Microbiome
Gladstone in the News
October 16, 2022
San Francisco Chronicle—The new bivalent COVID-19 booster shots are recommended for individuals age 5 and up who are at least two months past their last vaccine dose. Gladstone Investigator Nadia Roan explains that the bivalent boosters greatly increase the levels of antibodies that can prevent the Omicron variant from infecting cells.
Gladstone Experts
COVID-19
Virology
Roan Lab
Gladstone in the News
September 10, 2022
San Francisco Chronicle—New COVID-19 booster shots targeting both the ancestral virus and omicron strains are now available. Gladstone Investigator Nadia Roan weighs in on when people should get the jab, based on the timing of their last dose and whether they’ve been recently infected.
Gladstone Experts
COVID-19
Virology
Roan Lab
Gladstone in the News
September 1, 2022
San Francisco Chronicle—Senior Investigator Warner Greene, MD, PhD, says that it makes more sense to boost immunity with the newly approved bivalent vaccines targeting Omicron than with vaccines that aim at long-extinct variants of the coronavirus.
Gladstone Experts
COVID-19
Center for HIV Cure Research
Virology
Greene Lab
Gladstone in the News
August 29, 2022
Alex Marson, MD, PhD, director of the Gladstone-UCSF Institute of Genomic Immunology, comments on breakthrough technology developed in his lab that will greatly facilitate the large-scale engineering of immune cells for cell-based therapies.
Gladstone Experts
Genomic Immunology
Marson Lab
CRISPR/Gene Editing
Gladstone in the News
August 12, 2022
Wired—Measuring which genes are on and which are off in a cell usually requires killing it, meaning any measurement is simply a snapshot in time. Seth Shipman explains how his lab has circumvented this problem by re-engineering parts of a bacterial immune system to create a record of molecular events within a cell.
Gladstone Experts
Data Science and Biotechnology
Shipman Lab
CRISPR/Gene Editing
Gladstone in the News
August 2, 2022
Singularity Hub—Genomics tools allow scientists to get a glimpse of what genes are turned on in a cell at one particular moment, but understanding how genes are turned on or off over time, and in what order, has been impossible. Gladstone Investigator Seth Shipman has developed a biological recorder that keeps track of these events, offering a window into how cells change over time.
Gladstone Experts
Data Science and Biotechnology
Shipman Lab
CRISPR/Gene Editing
Gladstone in the News
July 26, 2022
ABC7 News—The federal government plans to roll out a new vaccine against the BA.5 Omicron variant now predominant in the US early this fall. Senior Investigator Warner Greene, MD, PhD, says that you might want to hold off for your next booster shot until you can get this new vaccine, which will offer better protection against currently circulating variants.
Gladstone Experts
COVID-19
Center for HIV Cure Research
Virology
Greene Lab
